About this site
GLP-1 Services is a price and value directory for compounded GLP-1 telehealth. It is a reader-supported editorial project from Generational Health™: some provider links are affiliate links, and we may earn a commission when you sign up, at no extra cost to you. We publish that plainly, apply one rubric to everyone, and show real trade-offs.
This site is a reader-supported editorial project from Generational Health™. We built GLP-1 Services because the hardest thing to pin down when shopping for a GLP-1 program is the real monthly cost, and a directory that puts price first is genuinely useful. Some of the provider links here are affiliate links: if you sign up through one, we may earn a commission at no additional cost to you. Rather than hide that arrangement, we disclose it on every page, next to the ranking, and here.
Affiliate compensation is a real relationship, and pretending otherwise would itself be the problem. Our answer is process: a published rubric, the same weights and scoring for every provider, real downsides stated in plain language, and sourced figures a reader can check. Compensation never changes a provider's score. If the data changed and a different provider offered better value on a like-for-like plan, our own rubric would move it up the table.
GLP-1 Services is reader-supported. Some of the provider links on this site are affiliate links, which means we may earn a commission if you sign up through one, at no additional cost to you. That is how the site is funded — we do not sell placement in the rankings, and no provider can pay to change its score or its position in the table. Whether a provider offers an affiliate arrangement has no bearing on the rubric, the weights, or the figures we publish. The full detail is in our affiliate disclosure and our methodology.
GLP-1 Services is researched and written by the GLP-1 Services editorial team. Our work is research-driven: we compile provider pricing, plan terms, and policies from primary sources — each program's own pricing pages and public disclosures — cross-check them against external review sites, and date every figure so a reader can see how current it is. No contributor is paid by a provider to write or to rank, and no provider previews these pages before they publish. Where we cannot confirm a value to a primary source, we show a placeholder rather than a guess.
A formal medical review by a licensed U.S. clinician is planned for this site. When that review is in place, the clinician's name, credentials, and review date will be published here and in the page byline. Until then, the clinical statements on this site — for example, that compounded GLP-1 medications are not FDA-approved — are checked by our editorial team against the cited sources. We do not publish invented credentials or approvals. For how the rankings are weighted and how pricing is sourced and dated, see our methodology.
We score compounded GLP-1 telehealth programs on price and value. The current directory covers ten programs, including MaxLife, Mochi Health, TrimRx, Eden, Ivim Health, Henry Meds, Zealthy, Willow, Fella Health, and Emerge. Providers that have moved away from compounded medication toward branded, FDA-approved products with insurance navigation — such as Ro and Hims & Hers — are mentioned for context but are not ranked in the compounded table, because they are a different product on a different cost basis.
We are a publisher, not a pharmacy. The telehealth providers we review are not drug manufacturers or compounding pharmacies; compounding is performed by their licensed pharmacy partners. This site does not prescribe, dispense, or provide medical care, and nothing here is medical advice.
Three rules govern everything we publish. First, real data only: we never invent prices, ratings, patients, reviews, or providers, and any value we cannot confirm appears as a bracketed placeholder rather than a guess. Second, sourced and dated: competitor figures are compiled from each provider's own published pages plus external review sites, labeled sourced June 2026, verify live, because this pricing moves quickly. Third, honest trade-offs: every provider, including MaxLife, gets real pros and real cons, and where MaxLife loses on a criterion, we say so.
Comparisons here are decision aids, not attacks. Where we note a provider's legal or regulatory situation, we describe it factually, neutrally, and with sources, and we flag that such matters change. We do not run this site as a link farm: it links within itself and out to the providers it reviews (affiliate links disclosed), and not into a web of other sites.
Because this content sits in a health category, a licensed U.S. clinician medical review is planned and will be named here once engaged; until then, our editorial team researches and fact-checks the claims on this site. Clinical statements — for example, that compounded GLP-1 medications are not FDA-approved, or that trial averages should be framed as averages rather than promises — are checked against the cited sources before publishing. The named reviewer and credential appear in the byline on each page.
the GLP-1 Services editorial team serves as medical reviewer. Our editorial team researches provider pricing and policies from primary sources and updates these pages as details change. Our reviewer checks that efficacy figures are presented as clinical-trial averages with an individual-results-vary caveat, that compounded medication is described as not FDA-approved wherever it is named, and that no content promises a specific health outcome.
Pricing is the core of this directory, so we treat it carefully. Provider prices come from each program's public pricing pages and pricing blogs, cross-checked against external review sites, then dated. We re-verify on a roughly monthly cadence and update the visible date when we do. Because many provider pages block automated checks, some numbers are verified by hand, and there can be lag between a provider's change and our update — so confirm live pricing on the provider's own site before you buy. The full sourcing and cadence detail is on our methodology page.
If you believe a figure is out of date or wrong, we want to fix it. email [email protected] Corrections to pricing or review data are made at the next scheduled review, or sooner for a material error, and the updated date is reflected on the page.